Home-Administered Trial of Direct Current Stimulation

The University of New South Wales34 enrolled

Overview

Transcranial Direct Current Stimulation (tDCS) is a novel non-invasive brain stimulation treatment that is effective with no significant side effects. It can potentially be self-administered by patients in their own homes with remote monitoring, substantially reducing treatment costs and increasing accessibility, including to remote areas. This study will evaluate the feasibility and efficacy of home-administered tDCS treatment for depression.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Major Depression

Interventions

Soterix tDCS machineDEVICE

Soterix tDCS machine - miniCT supervised neuromodulation system

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subject meets criteria for a DSM-IV Major Depressive Episode, lasting more than 4 weeks * Total MADRS score ≥ 20 Exclusion Criteria: * Diagnosis of any DSM-IV psychotic disorder * History of drug or alcohol abuse or dependence in the preceding 3 months * High suicide risk * Clinically defined neurological disorder or insult * Metal in the cranium or skull defects * Skin lesions on the scalp (e.g. cuts, abrasions, rashes) at the proposed electrode sites * Pregnancy

Locations (1)

Black Dog Institute

Randwick, Sydney, New South Wales, Australia

Outcomes

Primary Outcomes

Montgomery Asberg Depression Rating Scale for Depression (MADRS)

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.